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1.1. Combinatorial discovery of Fluorescent Pharmacophores
Labelling molecules with ﬂuorescent labels is an important
method for the study of a compound’s function within cells.
Although such ﬂuorophores can be small in size, their addition to
drug molecules can perturb the afﬁnity of the tracked molecule
for the target protein, thereby distorting the conclusions of any
study. Oneway to circumvent this interferencewould be to discover
ligands for important protein targets that are themselves ﬂuores-
cent. To this end a recent publication describes a parallel synthetic
approach to the discovery of ﬂuorescent pharmacophores.1
Imidazo[1,2-a]pyridines are naturally occurring compounds
that also possess pharmacological activity. Furthermore, they have
intrinsic ﬂuorescent properties. The imidazo[1,2-a]pyridine
structure (1) can be generated by a three-component Ugi reaction
(3-CR) of aromatic amidines with aldehydes and isocyanides. This
reaction was used to generate an array of different compounds to
permit the search for ﬂuorophores with ﬂuorescence in the visible
region.
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3-CRs were set up in 100 nL droplets aligned in a 800 spot
microarray on a hydrophobic surface glass slide. Each 1:1 DMSO/
water spot contained a different combination of amidines and
aldehyde, and volatile isocyanides could be added by adsorption
from the gas phase. Scandium triﬂate was used as the Lewis acid
catalyst and reaction validation demonstrated at least 10% conver-
sion to the aminoimidazo[1,2-a]pyridines – sufﬁcient to detect the
formation of ﬂuorescent compounds.
To identify new ﬂuorophores, 1600 unique combinations of
product were generated from eight heterocyclic amidines, 40
aldehydes and ﬁve isocyanides. After completion of the chemistry,
ﬂuorescence was measured by a microarray scanner at four
different ﬁlter settings. It was found that a number of amidines
produced compounds that ﬂuoresced with different colours, anddoi:10.1016/j.comche.2011.10.002
E-mail: nterrett@ensemblediscovery.comusing these amidines another library of 60 compounds was gener-
ated. The products were called ‘Flugis’ as an abbreviation of Fluo-
rescent Ugi products. Some of the best Flugis in this library had
extinction coefﬁcients in the range 1.1–2.7  104 M1 cm1, and
quantum yields in the range 0.2–0.9, giving ﬂuorophore bright-
nesses B of 104 M1 cm1, comparable to many commercial dyes.
Using this approach, a ﬂuorescent ligand for one of the recogni-
sed targets of imidazo[1,2-a]pyridines was developed. Zolpidem
(2) and analogues bind to the GABAA benzodiazepine receptor as
well as the peripheral benzodiazepine receptor known as the
translocator protein (TSPO). A collection of zolpidem analogues
were prepared using 3-CR, and these were examined for their
localisation in PC-3 prostate carcinoma cells. Of the compounds
made, one compound (3), had a localisation that closely matched
mitochondrial distribution. Incubation of cells with PK11195, a
highly speciﬁc TSPO ligand was shown to signiﬁcant displace ﬂuo-
rescent staining, conﬁrming that 3 is also a TSPO ligand.
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This study demonstrates that a parallel synthetic approach is
valuable in the discovery of autoﬂuorescing drug-like molecules
as bioimaging probes.2. A summary of the papers in this month’s issue
2.1. Solid-phase synthesis
A synthetic method for making lactic acid oligomers via solid-
phase synthesis under mild reaction conditions with up to 99%
yield has been presented. The ﬁne control of the chirality on each
lactic acid unit of the oligomers was easily achieved, and the
overall synthesis of the trimer and tetramer was completed in
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enantio-controlled lactic acids were also attempted through the
Yamaguchi macrolactonisation or the Mitsunobu reaction.2
2.2. Solution-phase synthesis
A library of pyridines and pyrimidines has been synthesised in
excellent yields employing microwave and ﬂow chemistry
methodologies. Work-up bottlenecks have been circumvented by
the use of supported reagents, and many of the ﬁnal compounds
have been studied in the solid state by single crystal X-ray
diffraction.3
2.3. Scaffolds and synthons for combinatorial libraries
A practical and rapid preparation of 3-benzyloxy-4-bromo and
3-benzyloxy-5-bromopicolinate esters has been developed in four
steps. Their viability as partners for cross-coupling reactions has
been evaluated in Suzuki–Miyaura, Hartwig–Buchwald, and Sono-
gashira reactions to allow the synthesis of biologically relevant tar-
gets. The preparation of these two highly functionalisable scaffolds
has not been described to date in the literature and could be used
as common building blocks for the preparation of several biologi-
cally active compounds or agrochemical products.4
2.4. Solid-phase supported reagents
Non-cross-linked polystyrene-supported (carbomethoxymeth-
yl)triphenylarsonium bromide and benzyltriphenylarsonium io-
dide have been synthesised. They have shown similar reactivities
compared with the free arsonium salts for the arsa-Wittig reaction.
The use of the polymer-supported reagents facilitated product
puriﬁcation and rendered the organoarsenic reagents easily sepa-
rable and recyclable.5
2.5. Novel resins, linkers and techniques
2-Aminoethanol has been used to successively replace hydra-
zine in the preparation of aminomethyl polystyrene resin thereby
facilitating puriﬁcation and by-product removal. The syntheses of
two polypeptides demonstrated that the use of the aminomethyl
polystyrene resin prepared in this manner was equal to or better
than that prepared using the hydrazine method.6
2.6. Library applications
Mycobacterium tuberculosis (Mtb) and Yersinia pestis (Yp) pro-
duce siderophores with scaffolds of nonribosomal peptide–polyke-
tide origin. Compounds with structural similarities to these
siderophores have been synthesised and evaluated as antimicrobi-
als against Mtb and Yp under iron-limiting conditions. Several new
antimicrobials have been identiﬁed, including some with increased
potency in the iron-limiting condition. This study illustrates the
possibility of screening compound libraries in both iron-rich and
iron-limiting conditions to identify antimicrobials that may selec-
tively target iron scarcity-adapted bacteria. It also highlights the
usefulness of building combinatorial libraries of compounds hav-
ing scaffolds with similarities to siderophores to feed into antimi-
crobial screening programs.7
A library of chemokine antagonists has been synthesised using a
combination of solid- and solution-phase chemistry. Structures of
known chemokine antagonists were used to produce a pharmaco-
phore which served to guide monomer selection. Several combina-
tions of monomers have resulted in providing novel chemokine
antagonists which in some cases display dual chemokine receptor
antagonism.8A potent, selective lead series that shows antagonism against
the human histamine H4 receptor has been discovered from thir-
teen actives identiﬁed in an HTS as part of a hit to lead program.
By focusing on ligand efﬁciency and concurrently using a diversity
based approach, active compounds based around 2,4-diaminopyr-
imidine were identiﬁed.9
A multicomponent reaction (MCR) approach involving palla-
dium catalysed C–C bond forming reaction has been developed
as a new strategy to access systematically modiﬁed functionalised
2-aminochromenes. This MCR involves the use of bromobenzalde-
hyde as a key component and has been exempliﬁed by making a
new compound library. Many of these compounds showed M.
tuberculosis H37Rv chorismate mutase inhibiting properties
in vitro.10
The medicinal chemistry of oral small molecule factor Xa inhib-
itors has been recently discussed, highlighting key advances that
led to clinical candidates and the ﬁrst licensed medicines. Identiﬁ-
cation of neutral ligands for the primary speciﬁcity pocket was a
key discovery; capitalised upon by structure based design and
combinatorial methods to deliver many variations on the theme;
but it was good medicinal chemistry practice, in the optimisation
of physical properties, which ultimately delivered efﬁcacious com-
pounds with adequate oral exposure.11
A library of new N-Mannich bases derived from 5-cyclopropyl-
5-phenyl- and 5-cyclopropyl-5-(4-chlorophenyl)-imidazolidine-
2,4-diones have been synthesised. Initial anticonvulsant screening
was performed using intraperitoneal (ip), maximal electroshock
(MES), and subcutaneous pentylenetetrazole (scPTZ) seizure tests.
The in vivo results in mice showed that all compounds were
effective, especially in the MES screen.12
With the non-speciﬁc toxicity of anticancer drugs to healthy
tissues upon systemic administration, formulations capable of
enhanced selectivity in delivery to the tumour mass and cells are
highly desirable. A combinatorial-designed strategy where the
nano-sized formulations are tailored based on the physicochemical
properties of the drug and the delivery needs have been investi-
gated. Individually functionalised C2 to C12 lipid- thiol-, and
poly(ethylene glycol)-modiﬁed dextran derivatives have been
synthesised via ‘click’ chemistry from O-pentynyl dextran and rel-
evant azides. These functionalised dextrans in combination with
anticancer drugs form nanoparticles by self-assembling in aqueous
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